Syneron Medical Ltd (ELOS) 10.16 $ELOS
Syneron Medical Appoints William Griffing to Newly Created Position of CEO of Syneron Candela North America
PR Newswire - Thu Feb 12, 6:30AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has enhanced its North American leadership team with the appointment of William Griffing to the newly created position of Chief Executive Officer of Syneron Candela North America, effective immediately. In this position, Mr. Griffing will be responsible for aligning and managing the Company's growth strategies for its North American business, with direct responsibility for sales, marketing, clinical education and customer service, all of which will report directly to him and to the relevant corporate managers. Mr. Griffing will also be part of Syneron's global management team.
ELOS: 10.16 (+0.07)
Syneron Medical to Report Fourth Quarter 2014 and Full Year 2014 Financial Results on February 18, 2015
PR Newswire - Thu Feb 05, 8:25AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2014 and full year 2014 financial results before the market opens on Wednesday, February 18, 2015. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 10.16 (+0.07)
Syneron Medical to Participate in the 2015 Leerink Global Healthcare Conference
PR Newswire - Thu Feb 05, 8:20AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Sarit Soccary Ben Yochanan, Vice President of Business Development and Strategy, and Brian Hayes, Vice President of Body Shaping Group, are scheduled to participate in the 2015 Leerink Global Healthcare Conference in New York City. Mrs. Soccary Ben Yochanan and Mr. Hayes will participate in a fireside chat presentation at the conference and conduct meetings with institutional investors.
ELOS: 10.16 (+0.07)
Syneron: Turning Fat Into Cash
Jonathan Fishman - at Seeking Alpha - Mon Jan 26, 10:49AM CST
ELOS: 10.16 (+0.07)
UltraShape Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment
PR Newswire Europe - Thu Jan 15, 10:21AM CST
- UltraShape Is Recognized As A Breakthrough In Non-Invasive Abdominal Fat Reduction Thanks To Its Painless And Effective Ultrasound Technology
ELOS: 10.16 (+0.07)
Nasdaq stocks posting largest volume increases
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ELOS: 10.16 (+0.07), INTG: 19.80 (+0.51), AGEN: 5.03 (-0.01), TRNS: 9.54 (+0.02), TFSC: 9.43 (+0.02), NLST: 1.86 (unch), MWIV: 189.72 (-0.17), NPSP: 45.88 (+0.03), LLEX: 1.17 (-0.09), NVC.TO: 11.27 (-0.23), NVCN: 9.08 (-0.17), TSRI: 4.24 (-0.01), HLSS: 16.15 (-0.14)
Syneron Medical Strengthens Management Team with Addition of Chief Brand Officer
PR Newswire - Mon Jan 12, 8:30AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced the expansion of its management team with the appointment of Ilan Nacasch to the newly created position of Chief Brand Officer, effectively immediately. He will be responsible for global marketing and branding of all Syneron-Candela products, with a strong focus on supporting the growth of the Body Shaping business in the U.S.
ELOS: 10.16 (+0.07), PG: 85.90 (-0.13)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
LOXO: 11.91 (-0.24), ELOS: 10.16 (+0.07), AMBA: 50.71 (-4.46), RGEN: 24.77 (-0.73), ADXS: 7.18 (+0.06), NBIX: 37.22 (+0.27), PDFS: 18.31 (+0.04), HALO: 14.73 (+0.23), VLCCF: 4.15 (-0.06), PKT: 8.99 (+0.11), ARNA: 4.55 (+0.02)
Syneron reports preliminary Q4 results
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 12:42PM CST
ELOS: 10.16 (+0.07)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
Syneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter Guidance
at The Street - Thu Jan 08, 9:52AM CST
Syneron Medical (ELOS) shares are climbing double digits after the company issued fourth quarter revenue guidance ahead of analysts' expectations.
ELOS: 10.16 (+0.07)
Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue
PR Newswire - Thu Jan 08, 6:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced preliminary fourth quarter 2014 revenue results. The Company expects revenue for the fourth quarter 2014 to be in the range of $72 to $74 million, representing growth compared to the year-ago quarter of between 20% and 24% on a pro-forma basis (excluding Syneron Beauty). This includes strong growth in product revenue in North America of approximately 50%, in the EMEA region of approximately 15% and in the APAC region of approximately 30%.
ELOS: 10.16 (+0.07)
North American Dermatology Diagnostic Devices Market Report 2014
M2 - Wed Dec 17, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddkrdp/micro_market) has announced the addition of the "Micro Market Monitor: North American Dermatology Diagnostic Devices Market" report to their offering. North America is considered to be the largest market in the dermatology diagnostic devices market segment, which is anticipated to grow at a CAGR of 9.6% from 2012 to 2013. Cosmetic surgeries and dermatological treatment is progressing steadily, which has resulted in fueling the overall demand of the dermatology diagnostic devices market. The main purpose of these dermatology devices is to assist in identifying and monitoring a patient's skin condition. With the growing awareness of skin disorders among the recent population, there is a rising incidence of dermatological procedures in the market. This has significantly laid a positive impact on the growing dependence of these innovative dermatological diagnostic techniques. The growing incidence of non-invasive aesthetic procedures have progressed the demand of dermatological diagnostic devices market in North America. Several other factors that have added to this growing demand are the prevalence of skin disorders, such as several tanning issues caused due to sun exposure, skin cancer, psoriasis, varicose veins, pigmentation, and vascular lesions. Advancements made in the field of dermatology have also resulted in the emergence of state-of-the-art diagnostic devices that deliver quick and accurate results. This huge demand of highly sophisticated diagnostic devices required to effectively examine patients and recommend necessary treatment measures have further influenced the North America dermatology diagnostic devices market to a large extent. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Research Methodology 4. Market Overview 5. U.S. Dermatology Diagnostic Devices By Types 6. U.S. Dermatology Treatmetn Devices By Types 7. Company Profiles - Alma Lasers, Ltd. - Ambicare Health Ltd. - Amd Global Telemedicine Inc - Applisonix Ltd - Biolitec Ag - Carl Zeiss - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Michelson Diagnostics Ltd. - Nikon Corporation - Mela Sciences, Inc. - Verisante Technology, Inc. - Syneron Medical Ltd. - Heine Optotechnik - Solta Medical, A Division Of Valeant Pharmaceuticals North America, Llc. - Photomedex, Inc. For more information visit http://www.researchandmarkets.com/research/dd...cro_market
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
India Aesthetic Lasers and Energy Devices Market Outlook to 2020: Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers
M2 - Thu Dec 11, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/43jz4h/india_aesthetic) has announced the addition of the "India Aesthetic Lasers and Energy Devices Market Outlook to 2020" report to their offering. Our new report, "India Aesthetic Lasers and Energy Devices Market Outlook to 2020", provides key market data on the India Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1 List of Tables 2 Introduction 3 Aesthetic Lasers and Energy Devices Market, India 4 Overview of Key Companies in India, Aesthetic Lasers and Energy Devices Market 5 Appendix Companies Mentioned: - Syneron Medical Ltd. - Cynosure, Inc. - Solta Medical, Inc. - Lumenis Ltd. - Alma Lasers, Ltd. - DEKA Laser Technologies, Inc. - Cutera, Inc. - Quanta System S.p.A - Ilooda Co., Ltd. For more information visit http://www.researchandmarkets.com/research/43..._aesthetic
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
Syneron Medical to supply holmium lasers to American Medical Systems for urology market
M2 - Tue Dec 09, 6:08AM CST
Aesthetic device company Syneron Medical (NasdaqGS:ELOS) reported on Monday the launch of a multi-year agreement to supply holmium lasers for the treatment of kidney stones to American Medical Systems (AMS).
ELOS: 10.16 (+0.07), NEWS: 10.58 (-0.19)
Syneron Candela Signs Agreement with American Medical Systems to Supply Holmium Laser for Urology
PR Newswire - Mon Dec 08, 8:31AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the signing of a multi-year agreement with American Medical Systems (AMS) to supply holmium lasers. AMS, an Endo International plc subsidiary, is a leading global provider of medical technologies for pelvic health conditions. This agreement furthers the partnership between AMS and New Star, a recently acquired subsidiary of Syneron, and its CoolTouch line of products, in supplying holmium lasers for the treatment of kidney stones. New Star helped pioneer the 2100nm Holmium wavelength technology in the early 1990s which is now the standard of care for the treatment of kidney stones and soft-tissue ablation by urologists.
ELOS: 10.16 (+0.07), NEWS: 10.58 (-0.19)
United Kingdom Aesthetic Lasers and Energy Devices Market Outlook 2014-2020
M2 - Tue Dec 02, 5:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/5wz2w4/united_kingdom) has announced the addition of the "United Kingdom Aesthetic Lasers and Energy Devices Market Outlook to 2020" report to their offering. "United Kingdom Aesthetic Lasers and Energy Devices Market Outlook to 2020", provides key market data on the United Kingdom Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Market size data for Aesthetic Lasers and Energy Devices market segments - Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices). - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Aesthetic Lasers and Energy Devices market. - Global corporate-level profiles of key companies operating within the Aesthetic Lasers and Energy Devices market. - Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Aesthetic Lasers and Energy Devices Market, United Kingdom 4 Overview of Key Companies in United Kingdom, Aesthetic Lasers and Energy Devices Market 5 Appendix Companies Mentioned - Syneron Medical Ltd. - Cynosure, Inc. - Solta Medical, Inc. - Lumenis Ltd. - Alma Lasers, Ltd. - DEKA Laser Technologies, Inc. - Quanta System S.p.A - Sciton Inc. For more information visit http://www.researchandmarkets.com/research/5w...ed_kingdom
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
Syneron Medical Appoints William Griffing to Newly Created Position of CEO of Syneron Candela North America
PR Newswire - Thu Feb 12, 6:30AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has enhanced its North American leadership team with the appointment of William Griffing to the newly created position of Chief Executive Officer of Syneron Candela North America, effective immediately. In this position, Mr. Griffing will be responsible for aligning and managing the Company's growth strategies for its North American business, with direct responsibility for sales, marketing, clinical education and customer service, all of which will report directly to him and to the relevant corporate managers. Mr. Griffing will also be part of Syneron's global management team.
ELOS: 10.16 (+0.07)
Syneron Medical to Report Fourth Quarter 2014 and Full Year 2014 Financial Results on February 18, 2015
PR Newswire - Thu Feb 05, 8:25AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2014 and full year 2014 financial results before the market opens on Wednesday, February 18, 2015. The earnings release will be available on Syneron's website at www.investors.syneron.com.
ELOS: 10.16 (+0.07)
Syneron Medical to Participate in the 2015 Leerink Global Healthcare Conference
PR Newswire - Thu Feb 05, 8:20AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Sarit Soccary Ben Yochanan, Vice President of Business Development and Strategy, and Brian Hayes, Vice President of Body Shaping Group, are scheduled to participate in the 2015 Leerink Global Healthcare Conference in New York City. Mrs. Soccary Ben Yochanan and Mr. Hayes will participate in a fireside chat presentation at the conference and conduct meetings with institutional investors.
ELOS: 10.16 (+0.07)
Syneron: Turning Fat Into Cash
Jonathan Fishman - at Seeking Alpha - Mon Jan 26, 10:49AM CST
ELOS: 10.16 (+0.07)
UltraShape Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment
PR Newswire Europe - Thu Jan 15, 10:21AM CST
- UltraShape Is Recognized As A Breakthrough In Non-Invasive Abdominal Fat Reduction Thanks To Its Painless And Effective Ultrasound Technology
ELOS: 10.16 (+0.07)
Nasdaq stocks posting largest volume increases
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ELOS: 10.16 (+0.07), INTG: 19.80 (+0.51), AGEN: 5.03 (-0.01), TRNS: 9.54 (+0.02), TFSC: 9.43 (+0.02), NLST: 1.86 (unch), MWIV: 189.72 (-0.17), NPSP: 45.88 (+0.03), LLEX: 1.17 (-0.09), NVC.TO: 11.27 (-0.23), NVCN: 9.08 (-0.17), TSRI: 4.24 (-0.01), HLSS: 16.15 (-0.14)
Syneron Medical Strengthens Management Team with Addition of Chief Brand Officer
PR Newswire - Mon Jan 12, 8:30AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced the expansion of its management team with the appointment of Ilan Nacasch to the newly created position of Chief Brand Officer, effectively immediately. He will be responsible for global marketing and branding of all Syneron-Candela products, with a strong focus on supporting the growth of the Body Shaping business in the U.S.
ELOS: 10.16 (+0.07), PG: 85.90 (-0.13)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
LOXO: 11.91 (-0.24), ELOS: 10.16 (+0.07), AMBA: 50.71 (-4.46), RGEN: 24.77 (-0.73), ADXS: 7.18 (+0.06), NBIX: 37.22 (+0.27), PDFS: 18.31 (+0.04), HALO: 14.73 (+0.23), VLCCF: 4.15 (-0.06), PKT: 8.99 (+0.11), ARNA: 4.55 (+0.02)
Syneron reports preliminary Q4 results
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 12:42PM CST
ELOS: 10.16 (+0.07)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
Syneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter Guidance
at The Street - Thu Jan 08, 9:52AM CST
Syneron Medical (ELOS) shares are climbing double digits after the company issued fourth quarter revenue guidance ahead of analysts' expectations.
ELOS: 10.16 (+0.07)
Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue
PR Newswire - Thu Jan 08, 6:00AM CST
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced preliminary fourth quarter 2014 revenue results. The Company expects revenue for the fourth quarter 2014 to be in the range of $72 to $74 million, representing growth compared to the year-ago quarter of between 20% and 24% on a pro-forma basis (excluding Syneron Beauty). This includes strong growth in product revenue in North America of approximately 50%, in the EMEA region of approximately 15% and in the APAC region of approximately 30%.
ELOS: 10.16 (+0.07)
North American Dermatology Diagnostic Devices Market Report 2014
M2 - Wed Dec 17, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddkrdp/micro_market) has announced the addition of the "Micro Market Monitor: North American Dermatology Diagnostic Devices Market" report to their offering. North America is considered to be the largest market in the dermatology diagnostic devices market segment, which is anticipated to grow at a CAGR of 9.6% from 2012 to 2013. Cosmetic surgeries and dermatological treatment is progressing steadily, which has resulted in fueling the overall demand of the dermatology diagnostic devices market. The main purpose of these dermatology devices is to assist in identifying and monitoring a patient's skin condition. With the growing awareness of skin disorders among the recent population, there is a rising incidence of dermatological procedures in the market. This has significantly laid a positive impact on the growing dependence of these innovative dermatological diagnostic techniques. The growing incidence of non-invasive aesthetic procedures have progressed the demand of dermatological diagnostic devices market in North America. Several other factors that have added to this growing demand are the prevalence of skin disorders, such as several tanning issues caused due to sun exposure, skin cancer, psoriasis, varicose veins, pigmentation, and vascular lesions. Advancements made in the field of dermatology have also resulted in the emergence of state-of-the-art diagnostic devices that deliver quick and accurate results. This huge demand of highly sophisticated diagnostic devices required to effectively examine patients and recommend necessary treatment measures have further influenced the North America dermatology diagnostic devices market to a large extent. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Research Methodology 4. Market Overview 5. U.S. Dermatology Diagnostic Devices By Types 6. U.S. Dermatology Treatmetn Devices By Types 7. Company Profiles - Alma Lasers, Ltd. - Ambicare Health Ltd. - Amd Global Telemedicine Inc - Applisonix Ltd - Biolitec Ag - Carl Zeiss - Cutera, Inc. - Cynosure, Inc. - Ellipse A/S - Fei Company - Fotofinder Systems Gmbh - Genesis Biosystems - Leica Microsystems - Lumenis Ltd. - Michelson Diagnostics Ltd. - Nikon Corporation - Mela Sciences, Inc. - Verisante Technology, Inc. - Syneron Medical Ltd. - Heine Optotechnik - Solta Medical, A Division Of Valeant Pharmaceuticals North America, Llc. - Photomedex, Inc. For more information visit http://www.researchandmarkets.com/research/dd...cro_market
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
India Aesthetic Lasers and Energy Devices Market Outlook to 2020: Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers
M2 - Thu Dec 11, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/43jz4h/india_aesthetic) has announced the addition of the "India Aesthetic Lasers and Energy Devices Market Outlook to 2020" report to their offering. Our new report, "India Aesthetic Lasers and Energy Devices Market Outlook to 2020", provides key market data on the India Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1 List of Tables 2 Introduction 3 Aesthetic Lasers and Energy Devices Market, India 4 Overview of Key Companies in India, Aesthetic Lasers and Energy Devices Market 5 Appendix Companies Mentioned: - Syneron Medical Ltd. - Cynosure, Inc. - Solta Medical, Inc. - Lumenis Ltd. - Alma Lasers, Ltd. - DEKA Laser Technologies, Inc. - Cutera, Inc. - Quanta System S.p.A - Ilooda Co., Ltd. For more information visit http://www.researchandmarkets.com/research/43..._aesthetic
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
Syneron Medical to supply holmium lasers to American Medical Systems for urology market
M2 - Tue Dec 09, 6:08AM CST
Aesthetic device company Syneron Medical (NasdaqGS:ELOS) reported on Monday the launch of a multi-year agreement to supply holmium lasers for the treatment of kidney stones to American Medical Systems (AMS).
ELOS: 10.16 (+0.07), NEWS: 10.58 (-0.19)
Syneron Candela Signs Agreement with American Medical Systems to Supply Holmium Laser for Urology
PR Newswire - Mon Dec 08, 8:31AM CST
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the signing of a multi-year agreement with American Medical Systems (AMS) to supply holmium lasers. AMS, an Endo International plc subsidiary, is a leading global provider of medical technologies for pelvic health conditions. This agreement furthers the partnership between AMS and New Star, a recently acquired subsidiary of Syneron, and its CoolTouch line of products, in supplying holmium lasers for the treatment of kidney stones. New Star helped pioneer the 2100nm Holmium wavelength technology in the early 1990s which is now the standard of care for the treatment of kidney stones and soft-tissue ablation by urologists.
ELOS: 10.16 (+0.07), NEWS: 10.58 (-0.19)
United Kingdom Aesthetic Lasers and Energy Devices Market Outlook 2014-2020
M2 - Tue Dec 02, 5:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/5wz2w4/united_kingdom) has announced the addition of the "United Kingdom Aesthetic Lasers and Energy Devices Market Outlook to 2020" report to their offering. "United Kingdom Aesthetic Lasers and Energy Devices Market Outlook to 2020", provides key market data on the United Kingdom Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Market size data for Aesthetic Lasers and Energy Devices market segments - Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices). - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Aesthetic Lasers and Energy Devices market. - Global corporate-level profiles of key companies operating within the Aesthetic Lasers and Energy Devices market. - Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Aesthetic Lasers and Energy Devices Market, United Kingdom 4 Overview of Key Companies in United Kingdom, Aesthetic Lasers and Energy Devices Market 5 Appendix Companies Mentioned - Syneron Medical Ltd. - Cynosure, Inc. - Solta Medical, Inc. - Lumenis Ltd. - Alma Lasers, Ltd. - DEKA Laser Technologies, Inc. - Quanta System S.p.A - Sciton Inc. For more information visit http://www.researchandmarkets.com/research/5w...ed_kingdom
ELOS: 10.16 (+0.07), CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57)
